Clinical Trial Update: Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis [Phase 4]

View source ↗

Summary

Phase 4 long-term safety and efficacy study of Calcitriol 3 mcg/g ointment in pediatric patients with plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis Vulgaris

Drugs mentioned

• Calcitriol 3 mcg/g ointment (calcitriol)

Snippet

Sponsor: Galderma R&D | Conditions: Psoriasis Vulgaris | Phase 4 | Status: COMPLETED | Results posted: 2019-11-29